Malawi’s health ministry has identified three additional mpox infections in Lilongwe, raising the confirmed case count to 11 since the virus was first detected in April. The country joins 15 other African nations grappling with rising mpox cases as health officials struggle with dwindling vaccine access and limited diagnostic and treatment capacity.

The Public Health Institute of Malawi reported that the latest patients are aged 17 to 41. Authorities are actively investigating the origin of transmission and tracking down those who may have been exposed.

The outbreak unfolds against the backdrop of sharp US financial cutbacks, particularly affecting HIV services. These cuts have severely impacted antiretroviral (ART) distribution, forcing some HIV-positive individuals to stop treatment, which increases their susceptibility to severe mpox symptoms.

According to district health spokesperson Richard Mvula, a common factor in several cases is weakened immunity. HIV, when untreated, can worsen the effects of mpox, while proper ART can help control disease progression.

Though cases are concentrated in the capital, the virus has surfaced in Mangochi, 240km away, signaling possible regional spread. Despite relatively low national numbers, the disease is surging across Africa. Africa CDC has documented over 52,000 cases and more than 1,770 deaths in 2025 alone.

Malawi’s overstretched health infrastructure—burdened by long travel distances, understaffing, and inadequate resources—faces mounting pressure. Public awareness remains low, with many relying on traditional remedies and lacking access to credible information.

Experts stress the urgency for vigilance, targeted outreach, and bolstered support.